Dr. Jeffrey R. Jay, M.D. »

Definium Therape shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2026-06-30 $20M 425k 47.04

More positions owned by Dr. Jeffrey R. Jay, M.D.

Abivax Sa Sponsored Ads (ABVX)
Vor Biopharma Com New (VOR)
Immunitybio Put Option (IBRX)
Vera Therapeutics Cl A (VERA)
Zura Bio Class A Ord Shs (ZURA)
Alumis (ALMS)
Sol-gel Technologies Shs New (SLGL)
Ultragenyx Pharmaceutical Put Option (RARE)
Definium Therapeutics Com Shs (DFTX)
Annexon (ANNX)
Oruka Therapeutics (ORKA)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Sagimet Biosciences Com Ser A (SGMT)
Contineum Therapeutics Cl A (CTNM)
Immix Biopharma (IMMX)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
Jupiter Topco
venBio Select Advisor
Henderson Group
Deep Track Capital
Geode Capital Management
State Street Corporation
Octagon Capital Advisors
Citadel Advisors
Commodore Capital
FMR
Alliancebernstein
Goldman Sachs Group
Vanguard Portfolio Management

View all funds holding Definium Therape